Dental
ITC delays ruling in Align Technology case against ClearCorrect
Align Technology (NSDQ:ALGN) said the International Trade Commission put off the target date for completing its review of a May 2013 decision that ClearCorrect infringed patents for Align’s Invisalign teeth-straightening technology.
Proxy war brews as activist investor Oracle targets Biolase board
Biolase cuts costs ahead of a potential sale, posts losses in Q4
Align Technology beats The Street with tripled Q4 profits
California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.
OrthoAccel lands $5M in equity round
OrthoAccel Technologies said it brought in $5 million in an equity offering.
The Houston-based company makes the AccelaDent device, which is designed to accelerate tooth movement using sonic technology.
The $5 million came from existing backers Healthpoint Capital and S3 Ventures, along with standing stockholders, according to a press release.
Henry Schein nabs 5 dental businesses from Arseus
Healthcare giant Henry Schein (NSDQ:HSIC) agreed to pay an undisclosed amount to acquire 5 dental businesses from Belgium-based Arseus, the companies announced this week.
Align Tech and execs escape finance fraud lawsuit
Dental implant maker faces sanctions for destroying evidence in patent infringement case
Implant Direct Manufacturing will face sanctions for destroying evidence in a patent infringement lawsuit filed by Zest IP Holdings, a federal magistrate judge ruled this week.
Henry Schein to buy a 60% stake in BioHorizons
Henry Schein (NSDQ:HSIC) said it plans to pick up a 60% stake in dental implant maker BioHorizons for an undisclosed amount.